https://news.medxy.ai/zh/vcars33-car-t-therapy-aml/Medxy AIzh2026-04-27T09:44:53-07:00供者来源的VCAR33 CAR T细胞疗法在移植后高风险AML中显示出前景 https://news.medxy.ai/ja/donor-vcar33-car-t-therapy-results/Medxy AIja2026-04-27T09:44:13-07:00ドナー由来のVCAR33 CAR T細胞療法が移植後の高リスクAMLで有望な結果を示す https://news.medxy.ai/vi/t-car-vcar33-therapy-aml/Medxy AIvi2026-04-27T09:43:21-07:00Liệu pháp tế bào T CAR VCAR33 có nguồn gốc từ người hiến tặng cho thấy triển vọng trong AML nguy cơ cao sau ghép tủy https://news.medxy.ai/donor-derived-vcar33-car-t-cell-therapy/Medxy AIen2026-04-27T09:40:18-07:00Donor-Derived VCAR33 CAR T-Cell Therapy Shows Promise in High-Risk AML Post-Transplant https://news.medxy.ai/zh/mild-copd-exacerbation-risk/Medxy AIzh2026-04-27T09:29:52-07:00轻度和单次中度慢性阻塞性肺疾病急性加重预测未来风险：基于社区队列研究的见解 https://news.medxy.ai/ja/mild-moderate-copd-exacerbation/Medxy AIja2026-04-27T09:29:13-07:00軽度および単発の中等度COPD悪化が将来のリスクを予測：コミュニティベースのコホート研究からの洞察 https://news.medxy.ai/vi/copd-outbreaks-prediction/Medxy AIvi2026-04-27T09:28:19-07:00Những đợt bùng phát COPD nhẹ và đơn lẻ vừa phải dự đoán nguy cơ trong tương lai: Những hiểu biết từ một nghiên cứu dựa vào cộng đồng https://news.medxy.ai/mild-copd-exacerbations-risk/Medxy AIen2026-04-27T09:25:21-07:00Mild and Single Moderate COPD Exacerbations Predict Future Risks: Insights from a Community-Based Cohort Study https://news.medxy.ai/zh/glp-1-receptor-agonists-vascular-protection/Medxy AIzh2026-04-27T09:24:25-07:00胰高血糖素样肽-1受体激动剂与血管保护：减轻高危2型糖尿病患者的系统性和眼部风险 https://news.medxy.ai/ja/glucagon-receptor-agonists/Medxy AIja2026-04-27T09:23:08-07:00グリカゴン様ペプチド-1受容体作動薬と血管保護：高リスク2型糖尿病患者の全身および眼疾患リスク軽減 https://news.medxy.ai/vi/glp-1-agonists-vessel-protection/Medxy AIvi2026-04-27T09:21:29-07:00Glucagon-Like Peptide-1 Receptor Agonists và Bảo Vệ Mạch Máu: Giảm Nguy Cơ Toàn Thân và Mắt ở Bệnh Nhân Đái Tháo Đường Loại 2 Có Nguy Cơ Cao https://news.medxy.ai/glp-1-receptor-agonists-vascular-protection/Medxy AIen2026-04-27T09:14:56-07:00Glucagon-Like Peptide-1 Receptor Agonists and Vascular Protection: Mitigating Systemic and Ocular Risks in High-Risk Type 2 Diabetes https://news.medxy.ai/zh/brolicizumab-vs-laser-therapy/Medxy AIzh2026-04-27T09:04:52-07:00布罗鲁西单抗在增殖性糖尿病视网膜病变中优于激光疗法：来自CONDOR试验的见解 https://news.medxy.ai/ja/brolucizumab-vs-laser-therapy-3/Medxy AIja2026-04-27T09:04:12-07:00Brolucizumab、レーザー療法を凌駕：CONDOR試験からの知見 https://news.medxy.ai/vi/brolucizumab-vs-laser-therapy-2/Medxy AIvi2026-04-27T09:03:33-07:00Brolucizumab hiệu quả hơn liệu pháp bằng laser trong bệnh võng mạc tiểu đường tăng sinh: Những nhận xét từ thử nghiệm CONDOR https://news.medxy.ai/brolucizumab-vs-laser-therapy/Medxy AIen2026-04-27T09:01:09-07:00Brolucizumab Outperforms Laser Therapy in Proliferative Diabetic Retinopathy: Insights from the CONDOR Trial https://news.medxy.ai/zh/dsdo-lenses-myopia-management/Medxy AIzh2026-04-27T08:59:40-07:00DSDO 镜片在儿童近视管理中表现出更优的轴向长度控制：一项多中心真实世界研究 https://news.medxy.ai/ja/dsdo-lens-myopia-management/Medxy AIja2026-04-27T08:58:54-07:00DSDOレンズは小児近視管理における軸長制御に優れた効果を示す：実世界の多施設研究 https://news.medxy.ai/vi/dsdo-control-display-study/Medxy AIvi2026-04-27T08:57:47-07:00Kính DSDO Hiển Thị Kiểm Soát Chiều Dài Trục Siêu Việt trong Quản Lý Cận Thị Nhi Đồng: Một Nghiên Cứu Đa Trung Tâm Thực Tế https://news.medxy.ai/dsdo-lenses-pediatric-myopia/Medxy AIen2026-04-27T08:55:12-07:00DSDO Lenses Show Superior Axial Length Control in Pediatric Myopia Management: A Real-World Multicenter Study https://news.medxy.ai/ja/immunotherapy-head-and-neck-cancer/Medxy AIja2026-04-27T08:15:41-07:00頭頸部がんにおける免疫療法の処方パターンと免疫関連有害事象 https://news.medxy.ai/vi/prescription-model-immunotoxicity/Medxy AIvi2026-04-27T08:14:36-07:00Mô hình kê đơn và các tác dụng phụ liên quan đến hệ miễn dịch trong điều trị ung thư đầu cổ https://news.medxy.ai/immunotherapy-head-neck-cancer/Medxy AIen2026-04-27T08:11:10-07:00Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Head and Neck Cancer https://news.medxy.ai/zh/radiation-otitis-recurrence-risk/Medxy AIzh2026-04-27T08:09:26-07:00放射诱发的分泌性中耳炎：细菌定植增加早期复发风险但缺乏长期预后价值 https://news.medxy.ai/ja/radiation-induced-ome-2/Medxy AIja2026-04-27T08:08:30-07:00放射線誘発性OME：細菌の定着が早期再発リスクを高めるが、長期予後には価値がない https://news.medxy.ai/vi/middle-ear-infection-radiation/Medxy AIvi2026-04-27T08:07:40-07:00Viêm tai giữa do xạ trị: Sự định cư của vi khuẩn làm tăng nguy cơ tái phát sớm nhưng không có giá trị tiên lượng dài hạn https://news.medxy.ai/radiation-induced-ome/Medxy AIen2026-04-27T08:04:40-07:00Radiation-Induced OME: Bacterial Colonization Elevates Early Recurrence Risk Yet Lacks Long-Term Prognostic Value https://news.medxy.ai/zh/68ga-pet-ct-aldo-surgery-outcome/Medxy AIzh2026-04-27T00:12:45-07:0068Ga-潘替克萨福 PET/CT 预测原发性醛固酮增多症手术后的预后 https://news.medxy.ai/ja/68ga-pentixafor-pet-ct-aldo-surgery-outcomes/Medxy AIja2026-04-27T00:11:27-07:0068Ga-Pentixafor PET/CT が主アルドステロン症手術の術後成績を予測 https://news.medxy.ai/vi/68ga-pentixafor-pet-ct-almost-aldosteron/Medxy AIvi2026-04-27T00:10:32-07:0068Ga-Pentixafor PET/CT Dự Đoán Kết Quả Sau Phẫu Thuật trong Bệnh Aldosteron Chủ Động https://news.medxy.ai/68ga-pentixafor-pet-ct-outcomes/Medxy AIen2026-04-27T00:07:18-07:0068Ga-Pentixafor PET/CT Predicts Postoperative Outcomes in Primary Aldosteronism Surgery https://news.medxy.ai/zh/early-enteral-nutrition-complications-2/Medxy AIzh2026-04-26T23:56:54-07:00早期肠内营养减少高危胰十二指肠切除术患者的术后并发症 https://news.medxy.ai/early-enteral-nutrition-pancreatoduodenectomy/Medxy AIen2026-04-26T23:51:27-07:00Early Enteral Nutrition Reduces Postoperative Complications in High-Risk Pancreatoduodenectomy Patients https://news.medxy.ai/zh/mucosal-impedance-gerd-tool-2/Medxy AIzh2026-04-26T23:44:08-07:00黏膜阻抗：一种用于优化GERD表型和手术决策的新诊断工具 https://news.medxy.ai/ja/mucosal-impedance-gerd-tool/Medxy AIja2026-04-26T23:43:31-07:00粘膜インピーダンス：GERDの診断と手術決定の向上に向けた新規ツール https://news.medxy.ai/vi/mucosal-resistance-gerd/Medxy AIvi2026-04-26T23:42:12-07:00Độ cản trở niêm mạc: Công cụ chẩn đoán mới để cải thiện phân loại GERD và quyết định phẫu thuật https://news.medxy.ai/mucosal-impedance-gerd-diagnosis/Medxy AIen2026-04-26T23:38:48-07:00Mucosal Impedance: A Novel Diagnostic Tool for Refining GERD Phenotyping and Surgical Decision-Making https://news.medxy.ai/zh/community-centered-education-improves-minority-women-awareness/Medxy AIzh2026-04-26T23:15:41-07:00以社区为中心的教育提高了少数族裔妇女对临床试验的认知和自我效能 https://news.medxy.ai/ja/community-education-minority-women/Medxy AIja2026-04-26T23:14:43-07:00コミュニティ中心の教育がマイノリティ女性の臨床試験に関する知識と自己効力感を向上させる https://news.medxy.ai/vi/community-focused-education/Medxy AIvi2026-04-26T23:13:52-07:00Giáo dục tập trung vào cộng đồng cải thiện kiến thức và lòng tự tin tham gia thử nghiệm lâm sàng cho phụ nữ thiểu số https://news.medxy.ai/community-education-clinical-trials/Medxy AIen2026-04-26T23:11:49-07:00Community-Centered Education Improves Clinical Trial Knowledge and Self-Efficacy Among Minoritized Women https://news.medxy.ai/zh/optimizing-delivery-timing-2/Medxy AIzh2026-04-26T18:34:28-07:00优化肥胖妊娠的分娩时机：孕前糖尿病在死胎风险中的关键作用 https://news.medxy.ai/ja/optimal-birth-timing-obesity/Medxy AIja2026-04-26T18:33:50-07:00肥満妊娠における出産タイミングの最適化：妊娠前の糖尿病が死産リスクに及ぼす重要な役割 https://news.medxy.ai/vi/optimizing-birth-time-obesity/Medxy AIvi2026-04-26T18:33:03-07:00Tối ưu hóa thời gian sinh nở cho thai kỳ béo phì: Vai trò quan trọng của tiểu đường tiền thai kỳ trong nguy cơ thai chết lưu https://news.medxy.ai/optimizing-delivery-timing/Medxy AIen2026-04-26T18:29:44-07:00Optimizing Delivery Timing for Obese Pregnancies: The Critical Role of Pre-Pregnancy Diabetes in Stillbirth Risk https://news.medxy.ai/acog-2026-cervical-cancer-guidelines/Medxy AIen2026-04-26T09:00:07-07:00ACOG Endorses Updated 2026 Cervical Cancer Screening Guidelines: Key Changes and Implications https://news.medxy.ai/zh/glp-1-sglt-2-combo-therapy/Medxy AIzh2026-04-25T22:22:39-07:00GLP-1受体激动剂与SGLT-2抑制剂联合治疗可降低MASLD和2型糖尿病患者的肝脏和心血管风险 https://news.medxy.ai/ja/glp-1-sglt-2-combination-therapy/Medxy AIja2026-04-25T22:21:17-07:00GLP-1受容体作動薬とSGLT-2阻害薬の併用療法は、MASLDおよび2型糖尿病患者の肝臓および心血管リスクを低下させる https://news.medxy.ai/vi/glp-1-sglt-2-therapy/Medxy AIvi2026-04-25T22:19:46-07:00Liệu pháp kết hợp giữa các chất kích thích thụ thể GLP-1 và các chất ức chế SGLT-2 giảm nguy cơ gan và tim mạch ở bệnh MASLD và tiểu đường tuýp 2 https://news.medxy.ai/glp1-sglt2-combination-therapy/Medxy AIen2026-04-25T22:17:15-07:00Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes https://news.medxy.ai/zh/cd16-%ce%b3d-t-cells-hbv/Medxy AIzh2026-04-25T21:33:52-07:00CD16+ γδ T 细胞：通过抗体依赖性细胞毒作用控制 HBV 病毒的新角色 https://news.medxy.ai/ja/cd16-gamma-d-t-cells-hbv-control-2/Medxy AIja2026-04-25T21:33:11-07:00CD16+ γδ T細胞：抗体依存性細胞障害を介したHBVウイルス制御の新たなプレーヤー https://news.medxy.ai/vi/cd16-gamma-t-cells-hbv/Medxy AIvi2026-04-25T21:31:59-07:00Tế bào CD16+ γδ T: Một yếu tố mới trong kiểm soát vi-rút HBV thông qua độc tính tế bào phụ thuộc kháng thể https://news.medxy.ai/cd16-gamma-d-t-cells-hbv-control/Medxy AIen2026-04-25T21:27:28-07:00CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity https://news.medxy.ai/zh/clonal-lymphocyte-expansion/Medxy AIzh2026-04-25T20:10:58-07:00克隆淋巴细胞扩增和JAK-STAT突变驱动难治性乳糜泻 https://news.medxy.ai/ja/clonal-lymphocyte-proliferation-celiac-disease/Medxy AIja2026-04-25T20:09:43-07:00クローン性リンパ球の増殖とJAK-STAT変異が難治性セリアック病を駆動 https://news.medxy.ai/vi/clonal-expansion-celiac-disease/Medxy AIvi2026-04-25T20:08:01-07:00Sự Mở Rộng Clonal của Bạch Huyết Bào và Biến Đổi JAK-STAT Kích Thúc Bệnh Celiac Kháng Trị https://news.medxy.ai/clonal-lymphocyte-expansions/Medxy AIen2026-04-25T20:03:55-07:00Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease https://news.medxy.ai/zh/evt-superior-efficacy/Medxy AIzh2026-04-25T19:52:13-07:00EVT在前脑动脉闭塞性卒中显示优越疗效：来自ORIENTAL-MeVO注册研究的见解 https://news.medxy.ai/ja/evt-fronto-cerebral-stroke/Medxy AIja2026-04-25T19:51:43-07:00EVTは前頭葉大脳動脈閉塞脳卒中で優れた結果を示す：ORIENTAL-MeVOレジストリからの洞察 https://news.medxy.ai/vi/evt-results-stroke-oriental-mevo/Medxy AIvi2026-04-25T19:51:08-07:00EVT Hiển Thị Kết Quả Tốt Hơn Trong Đột Quỵ Hẹp Mạch Động Mạch Não Trước: Những Nhận Định từ Đăng Ký ORIENTAL-MeVO https://news.medxy.ai/evt-superior-outcomes-stroke/Medxy AIen2026-04-25T19:48:57-07:00EVT Shows Superior Outcomes in Anterior Cerebral Artery Occlusion Stroke: Insights from the ORIENTAL-MeVO Registry https://news.medxy.ai/zh/best-sleep-duration-epilepsy-risk/Medxy AIzh2026-04-25T18:55:55-07:00最佳睡眠时长可减轻局灶性癫痫的认知衰退和痴呆风险：来自英国生物银行研究的见解 https://news.medxy.ai/ja/optimal-sleep-duration-epilepsy-risk/Medxy AIja2026-04-25T18:54:47-07:00最適な睡眠時間は局灶性てんかんにおける認知機能低下と認知症リスクを軽減：UK Biobank研究からの洞察 https://news.medxy.ai/vi/optimal-sleep-time-epilepsy/Medxy AIvi2026-04-25T18:53:26-07:00Thời gian ngủ tối ưu giảm thiểu suy giảm nhận thức và nguy cơ mất trí trong động kinh cục bộ: Những hiểu biết từ nghiên cứu UK Biobank https://news.medxy.ai/optimal-sleep-cognitive-health/Medxy AIen2026-04-25T18:49:52-07:00Optimal Sleep Duration Mitigates Cognitive Decline and Dementia Risk in Focal Epilepsy: Insights from the UK Biobank Study